ArticleCureus2025
pREBOA Abroad: Leveraging Partial Aortic Occlusion for Stabilization and Transport in Ukraine.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Resuscitative endovascular balloon occlusion of the aorta in combat and austere environments.World journal of critical care medicine · 2026Article
- Resuscitative endovascular balloon occlusion of the aorta in trauma patients: Past, present, and future.Chinese journal of traumatology = Zhonghua chuang shang za zhi · 2026Review
- [Resuscitative endovascular balloon occlusion of the aorta-REBOA for bleeding control in the prehospital context : Overview of available cases and evaluation of the evidence].Die Anaesthesiologie · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The war in Ukraine highlights the challenges in providing combat casualty care when both nations are near-peer adversaries. Providing timely definitive hemorrhage control within one hour of injury, as the US military and its allies have grown accustomed, is unrealistic. Stabilization points (SP) in Ukraine are forced to provide prolonged field care to exsanguinating patients with little resources while waiting extended periods of time for patient transport. pREBOA-PRO™ (Prytime Medical, Boerne, TX)has been suggested as a bridge to this problem as it can provide temporary hemorrhage control, stabilize the patient, and limit distal ischemic consequences when used for partial aortic occlusion. We discuss a patient who suffered a traumatic arm amputation and intra-abdominal injuries managed with pREBOA-PRO™. This partial aortic occlusion provided an increase in central perfusion pressure, temporary hemorrhage control, and time for patient transport to definitive hemorrhage control. This serves as proof of concept that pREBOA-PRO™ and partial aortic occlusion can stabilize a patient, provide longer safe occlusion times, and aid in transport in austere environments while mitigating distal ischemic consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.